Literature DB >> 11469992

Intestinal Gas.

Rebecca N. Fink1, Anthony J. Lembo.   

Abstract

The most common symptoms associated with intestinal gas are excessive eructation, flatulence, and abdominal bloating and distention. Unfortunately, few therapies have been shown to be effective in treating these symptoms. Excessive eructation can be treated by decreasing excessive air swallowing. Bloating and gaseous distension can improve in some patients by avoiding foods containing partially digested or absorbed polysaccharides, by taking replacement enzymes (such as alfa-galactosidase or lactase), or by taking antibiotics directed toward altering the colonic flora. Activated charcoal or prokinetic agents (such as tegaserod and metoclopramide) also can be effective options in some patients. For noxious odor associated with flatus, bismuth subsalicylate or the charcoal cushion may improve patients' symptoms.

Entities:  

Year:  2001        PMID: 11469992     DOI: 10.1007/s11938-001-0059-6

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  21 in total

Review 1.  An understanding of excessive intestinal gas.

Authors:  F L Suarez; M D Levitt
Journal:  Curr Gastroenterol Rep       Date:  2000-10

2.  Hysterical type of nongaseous abdominal bloating.

Authors:  W C ALVAREZ
Journal:  Arch Intern Med (Chic)       Date:  1949-08

3.  Bismuth subsalicylate markedly decreases hydrogen sulfide release in the human colon.

Authors:  F L Suarez; J K Furne; J Springfield; M D Levitt
Journal:  Gastroenterology       Date:  1998-05       Impact factor: 22.682

Review 4.  Managing bloating, flatus and flatulence.

Authors:  A J Bell; P J Ciclitira
Journal:  Practitioner       Date:  2000-04

5.  Quantitative analysis of bowel gas using plain abdominal radiograph in patients with irritable bowel syndrome.

Authors:  A Koide; T Yamaguchi; T Odaka; H Koyama; T Tsuyuguchi; H Kitahara; M Ohto; H Saisho
Journal:  Am J Gastroenterol       Date:  2000-07       Impact factor: 10.864

6.  Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance.

Authors:  T G Ganiats; W A Norcross; A L Halverson; P A Burford; L A Palinkas
Journal:  J Fam Pract       Date:  1994-11       Impact factor: 0.493

Review 7.  Misadventures with activated charcoal and recommendations for safe use.

Authors:  L S Mauro; J J Nawarskas; V F Mauro
Journal:  Ann Pharmacother       Date:  1994 Jul-Aug       Impact factor: 3.154

8.  Gas production in human ingesting a soybean flour derived from beans naturally low in oligosaccharides.

Authors:  F L Suarez; J Springfield; J K Furne; T T Lohrmann; P S Kerr; M D Levitt
Journal:  Am J Clin Nutr       Date:  1999-01       Impact factor: 7.045

9.  Abnormal colonic fermentation in irritable bowel syndrome.

Authors:  T S King; M Elia; J O Hunter
Journal:  Lancet       Date:  1998-10-10       Impact factor: 79.321

10.  Controlled trial of metoclopramide in the treatment of flatulent dyspepsia.

Authors:  A G Johnson
Journal:  Br Med J       Date:  1971-04-03
View more
  1 in total

1.  Efficacy and tolerability of α-galactosidase in treating gas-related symptoms in children: a randomized, double-blind, placebo controlled trial.

Authors:  Giovanni Di Nardo; Salvatore Oliva; Federica Ferrari; Saverio Mallardo; Giovanni Barbara; Cesare Cremon; Marina Aloi; Salvatore Cucchiara
Journal:  BMC Gastroenterol       Date:  2013-09-24       Impact factor: 3.067

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.